In vitro hypoxic cytotoxicity and hypoxic radiosensitization

Intra- and intertumor heterogeneities in total, chronic, and acute hypoxia in xenografted squamous cell carcinomas

(2012) C.-A. Maftei et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Basal HIF-1α expression levels are not predictive for radiosensitivity of human cancer cell lines

(2012) D. Schilling et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Acute versus chronic hypoxia in tumors

(2012) C. Bayer et al.   STRAHLENTHERAPIE UND ONKOLOGIE

EMT: A new vision of hypoxia promoting cancer progression

(2011) Jian Jiang et al.   CANCER BIOLOGY & THERAPY

Hypoxia Predicts Aggressive Growth and Spontaneous Metastasis Formation from Orthotopically Grown Primary Xenografts of Human Pancreatic Cancer

(2011) Q. Chang et al.   CANCER RESEARCH

Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways

(2011) Nadine Rohwer et al.   DRUG RESISTANCE UPDATES

Evaluation of the In vivo Radiosensitizing Activity of Etanidazole Using Tumor-bearing Chick Embryo

(2011) Chiaki ABE et al.   JOURNAL OF RADIATION RESEARCH

Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck – A systematic review and meta-analysis

(2011) Jens Overgaard   RADIOTHERAPY AND ONCOLOGY

Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck

(2011) Kasper Toustrup et al.   RADIOTHERAPY AND ONCOLOGY

Small interfering RNA targeting HIF-1α reduces hypoxia-dependent transcription and radiosensitizes hypoxic HT 1080 human fibrosarcoma cells in vitro

(2011) Adrian Staab et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Quantitative assessment of hypoxia subtypes in microcirculatory supply units of malignant tumors Using (immuno-)fluorescence techniques

(2011) Constantin-Alin Maftei et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Radiosensitising agents for the radiotherapy of cancer: advances in traditional and hypoxia targeted radiosensitisers

(2009) Pierre Bischoff et al.   EXPERT OPINION ON THERAPEUTIC PATENTS